Result : 7

New antibiotics to deal with antibiotic resistance

The current increase in antibiotic resistance exposes to the risk of therapeutic impasse. To deal with this public health problem, developing new antibiotics that are effective (directly or in...
 Pauline Huriez, Benoît Pilmis. September 2023, page 6

Antimicrobial resistance in human and veterinary medicine: where are we?

In both human and veterinary medicine, the evolution of antimicrobial resistance is worrying for some antibiotics or bacterial species, but less for others. In humans and animals, the picture for...
 Laurence Armand-Lefèvre, Jean-Yves Madec. December 2024, page 14

Risk of acquiring antibiotic-resistant bacteria and travel

The continuing expansion of international tourism increases the opportunities of contact with diverse epidemiological environments, leading to both a risk of bacterial acquisition or infection for...
 Paul-Henri Consigny, Laurence Armand-Lefèvre. December 2024, page 20

Shortened antimicrobial therapy duration

Antibiotic treatment durations represent an important field of current clinical research. Indeed, shortening antibiotic duration during bacterial pathologies has several advantages: reducing the...
 Aurélien Dinh, Bernard Castan. December 2024, page 26

Hospital antimicrobial stewardship

Hospital antimicrobial stewardship programs have been thought to preserve the efficacy of antimicrobials for the treatment of human and animal bacterial infections. They must apply for every...
 Philippe Lesprit, Patricia Pavese. December 2024, page 34

How to read new antimicrobial susceptibility testing results?

Antimicrobial susceptibility testing (AST) results (formerly 'susceptible', 'intermediate' and 'resistant') are now expressed with the new susceptibility categories 'susceptible, standard dosing...
 Frédéric Schramm, Raphaël Lepeule. December 2024, page 40

New challenge in antibacterial treatments: 10 key messages

 Pierre Tattevin. December 2024, page 51